Literature DB >> 35150361

In systemic sclerosis TAPSE/sPAP ratio is correlated with ventilatory efficiency and exercise capacity assessed by CPET.

Amalia Colalillo1, Chiara Pellicano1, Antonella Romaniello2, Edoardo Rosato3.   

Abstract

OBJECTIVES: The aim of the study was to evaluate the correlation between cardiopulmonary exercise testing (CPET) parameters and right ventricular echocardiographic parameters for pulmonary arterial hypertension screening in a cohort of systemic sclerosis (SSc) patients. Methods forty SSc patients were examined using CPET and resting transthoracic echocardiography. CPET parameters analyzed were minute ventilation/carbon dioxide production (VE/VCO2) slope and maximum oxygen uptake (VO2 max); echocardiographic parameters were systolic pulmonary artery pressure (sPAP), tricuspid annular plane systolic excursion (TAPSE), and TAPSE/sPAP ratio. Results a positive correlation was observed between VE/VCO2 slope and age (r = 0.415, p < 0.01) and sPAP (r = 0.461, p < 0.01), conversely, a negative correlation was found between VE/VCO2 slope and TASPE/sPAP ratio (r = - 0.521, p = 0.001). VO2 max showed an inverse correlation with age (r = - 0.367, p < 0.05) and sPAP (r = - 0.387, p < 0.05) and a positive correlation with TAPSE/sPAP ratio (r = 0.521, p < 0.01). On stepwise linear regression analysis, VE/VCO2 slope was significantly correlated with TAPSE/sPAP ratio (β coefficient = - 0.570; p < 0.0001), as well as VO2 max was significantly correlated with TAPSE/sPAP ratio (β coefficient = 0.518; p = 0.001). Conclusion in SSc patients, TAPSE/sPAP ratio is the echocardiographic parameter of RV function which showed the best correlation with ventilatory efficiency and exercise capacity.
© 2022. The Author(s).

Entities:  

Keywords:  Cardiopulmonary exercise testing; Echocardiography; Pulmonary hypertension; Systemic sclerosis; TAPSE/sPAP ratio

Year:  2022        PMID: 35150361     DOI: 10.1007/s10238-022-00804-5

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  17 in total

1.  Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes.

Authors:  Zoe Brown; Susanna Proudman; Kathleen Morrisroe; Wendy Stevens; Dylan Hansen; Mandana Nikpour
Journal:  Semin Arthritis Rheum       Date:  2021-04-04       Impact factor: 5.532

2.  Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension.

Authors:  Khodr Tello; Jens Axmann; Hossein A Ghofrani; Robert Naeije; Newroz Narcin; Andreas Rieth; Werner Seeger; Henning Gall; Manuel J Richter
Journal:  Int J Cardiol       Date:  2018-09-01       Impact factor: 4.164

3.  Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis.

Authors:  Daniel Dumitrescu; Christian Nagel; Gabor Kovacs; Tom Bollmann; Michael Halank; Jörg Winkler; Martin Hellmich; Ekkehard Grünig; Horst Olschewski; Ralf Ewert; Stephan Rosenkranz
Journal:  Heart       Date:  2017-01-06       Impact factor: 5.994

4.  Mapping and predicting mortality from systemic sclerosis.

Authors:  Muriel Elhai; Christophe Meune; Marouane Boubaya; Jérôme Avouac; Eric Hachulla; Alexandra Balbir-Gurman; Gabriela Riemekasten; Paolo Airò; Beatriz Joven; Serena Vettori; Franco Cozzi; Susanne Ullman; László Czirják; Mohammed Tikly; Ulf Müller-Ladner; Paola Caramaschi; Oliver Distler; Florenzo Iannone; Lidia P Ananieva; Roger Hesselstrand; Radim Becvar; Armando Gabrielli; Nemanja Damjanov; Maria J Salvador; Valeria Riccieri; Carina Mihai; Gabriella Szücs; Ulrich A Walker; Nicolas Hunzelmann; Duska Martinovic; Vanessa Smith; Carolina de Souza Müller; Carlo Maurizio Montecucco; Daniela Opris; Francesca Ingegnoli; Panayiotis G Vlachoyiannopoulos; Bojana Stamenkovic; Edoardo Rosato; Stefan Heitmann; Jörg H W Distler; Thierry Zenone; Matthias Seidel; Alessandra Vacca; Ellen De Langhe; Srdan Novak; Maurizio Cutolo; Luc Mouthon; Jörg Henes; Carlo Chizzolini; Carlos Alberto von Mühlen; Kamal Solanki; Simona Rednic; Lisa Stamp; Branimir Anic; Vera Ortiz Santamaria; Maria De Santis; Sule Yavuz; Walter Alberto Sifuentes-Giraldo; Emmanuel Chatelus; Jiri Stork; Jacob van Laar; Esthela Loyo; Paloma García de la Peña Lefebvre; Kilian Eyerich; Vanesa Cosentino; Juan Jose Alegre-Sancho; Otylia Kowal-Bielecka; Grégoire Rey; Marco Matucci-Cerinic; Yannick Allanore
Journal:  Ann Rheum Dis       Date:  2017-08-23       Impact factor: 19.103

5.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

6.  Ventilatory efficiency in pulmonary vascular diseases.

Authors:  Jason Weatherald; Brianne Philipenko; David Montani; Pierantonio Laveneziana
Journal:  Eur Respir Rev       Date:  2021-07-20

7.  Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension.

Authors:  Khodr Tello; Jun Wan; Antonia Dalmer; Rebecca Vanderpool; Hossein A Ghofrani; Robert Naeije; Fritz Roller; Emad Mohajerani; Werner Seeger; Ulrike Herberg; Natascha Sommer; Henning Gall; Manuel J Richter
Journal:  Circ Cardiovasc Imaging       Date:  2019-09-10       Impact factor: 7.792

8.  Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension.

Authors:  Roland Wensel; Darrel P Francis; F Joachim Meyer; Christian F Opitz; Leonhard Bruch; Michael Halank; Jörg Winkler; Hans-Jürgen Seyfarth; Sven Gläser; Friedrich Blumberg; Anne Obst; Michael Dandel; Roland Hetzer; Ralf Ewert
Journal:  Int J Cardiol       Date:  2012-04-10       Impact factor: 4.164

9.  Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.

Authors:  Marc Humbert; Christophe Guignabert; Sébastien Bonnet; Peter Dorfmüller; James R Klinger; Mark R Nicolls; Andrea J Olschewski; Soni S Pullamsetti; Ralph T Schermuly; Kurt R Stenmark; Marlene Rabinovitch
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

10.  Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis.

Authors:  Ralf Ewert; Till Ittermann; Dirk Habedank; Matthias Held; Tobias J Lange; Michael Halank; Jörg Winkler; Sven Gläser; Horst Olschewski; Gabor Kovacs
Journal:  BMC Pulm Med       Date:  2019-11-29       Impact factor: 3.317

View more
  1 in total

1.  Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement.

Authors:  Francesco Iannazzo; Chiara Pellicano; Amalia Colalillo; Cesarina Ramaccini; Antonella Romaniello; Antonietta Gigante; Edoardo Rosato
Journal:  Clin Exp Med       Date:  2022-07-25       Impact factor: 5.057

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.